2017 Neil Mackenzie Mentorship Excellence Award

Since 2015, the Centre for Blood Research (CBR) has offered an award to honour the memory of Neil Mackenzie and to recognize the mentorship excellence he provided within the CBR community. Nominations for this award are open to any member of the CBR (with the exception of PIs). CBR members nominate their colleagues and lab mates who exhibit excellence in mentorship, enthusiasm,…
Read More
Cancers, including Hodgkin lymphoma can change their face over time. Specifically in Hodgkin lymphoma, we have shown that the so called tumor microenvironment changes form initial diagnosis to relapse. This has implications for prognostication, treatment resistance and the rational choice of therapies in the era of personalized medicine. In the Journal of Clinical Oncology publication, we have developed  an assay, called RHL30, at the time point of disease relapse when testing is most needed for physicians...
Read More
Almost half of Canadians – 43 per cent –  believe scientific findings are ‘a matter of opinion,’ a poll released Monday shows. At the same time, 81 per cent said that scientific findings were ‘objective facts,’ which means that over a third of the poll’s respondents, 38 per cent, believe both. Those who described themselves as ‘intuitive/gut feel decision-makers’ were more…
Read More
STEMCELL Technologies has signed an exclusive license with Propagenixof Rockville, MD to commercialize its patented EpiX™ technology, a novel and revolutionary cell culture medium that enables unprecedented expansion of tissue-resident epithelial stem cells without any genetic manipulation. EpiX™ outperforms current state-of-the-art cell culture systems, which typically yield fewer than 20 population doublings before the cells senesce. Epithelial stem cells derived from many…
Read More
Due to their unique optical and electromagnetic properties, inorganic nanoparticles are extremely promising for therapeutics as well as diagnostics (theranostics: therapeutic + diagnostic). For example, iron oxide nanoparticles can be used as an MRI contrast agent but also can generate heat when stimulated by an external electromagnetic and can be used to destroy cancer...
Read More
he upward trajectory of the cannabis industry has garnered comparisons to the Internet boom of the early 2000s, as North American sales are on pace to record a compound annual growth rate of 25 percent through 2021, according to Arcview Market Research (1). These comparisons are certainly attention-grabbing, but the full potential of the evolving marijuana market could be even…
Read More

SFU Welcomes Tania Bubela as New Dean of Health Sciences

Tania Bubela, a health law and policy researcher with an extensive health biotechnology and legal background, is Simon Fraser University’s new dean of health sciences. Bubela joins SFU from the University of Alberta (U of A). A professor in the School of Public Health, she also served as associate dean of research (2014-2016). Prior to joining the school, Bubela clerked…
Read More
We present the structures of Type IV pili from two bacterial pathogens of major medical importance, Pseudomonas aeruginosa and Neisseria gonorrhoeae. P. aeruginosa use Type IV pili to adhere to the lungs of cystic fibrosis patients, causing deadly infections, and N. gonorrhoeae use their Type IV pili to adhere to and invade cells of the urogenital tract to cause the sexually transmitted disease gonorrhea. These Type IV pili...
Read More

Congratulations to the BCCHRI NSERC Grant Recipients!

We are pleased to congratulate the BCCHR investigators who were recently awarded Natural Sciences and Engineering Research Council of Canada (NSERC) Grants. Dr. Todd Woodward, Principal Investigator: Discovery Grant – Project: “Delineation of a task-demand dependent rostrocaudal gradient in the salience network” Research Tools and Instruments Grant – Project: “High-density neuromodulation using network-based transcranial alternating current stimulation” Dr. Christine Tipper,…
Read More
B.C. researchers are leading an new offensive against sepsis, one of the leading causes of death in Canada. Sepsis is a condition that’s caused by an “overwhelming immune response to an infection,” according to Statistics Canada. That can lead to “widespread inflammation, swelling and blood clotting,” as well as organ damage. When not treated quickly, it can result in organ failure…
Read More


Win $500 USD towards your registration fee for a cell and gene therapy conference